Do nondiabetic patients undergoing coronary artery bypass grafting surgery require intraoperative management of hyperglycemia?
Do nondiabetic patients undergoing coronary artery bypass grafting surgery require intraoperative management of hyperglycemia?
نویسندگان: رسول آذرفرین , داریوش شیخ زاده , میر موسی میری نژاد , عیسی بیله جانی , آذین علیزاده
کلمات کلیدی: blood glucose;
coronary artery bypass;
hyperglycemia;
insulin
نشریه: 48874 , , , 2011
| نویسنده ثبت کننده مقاله |
داریوش شیخ زاده |
| مرحله جاری مقاله |
تایید نهایی |
| دانشکده/مرکز مربوطه |
مرکز تحقیقات قلب وعروق |
| کد مقاله |
71416 |
| عنوان فارسی مقاله |
Do nondiabetic patients undergoing coronary artery bypass grafting surgery require intraoperative management of hyperglycemia? |
| عنوان لاتین مقاله |
Do nondiabetic patients undergoing coronary artery bypass grafting surgery require intraoperative management of hyperglycemia? |
| ناشر |
5 |
| آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ |
خیر |
| عنوان نشریه (خارج از لیست فوق) |
|
| نوع مقاله |
Original Article |
| نحوه ایندکس شدن مقاله |
ایندکس شده سطح چهار – سایر سایت های تخصصی |
| آدرس لینک مقاله/ همایش در شبکه اینترنت |
|
| Objective: To study the effect of blood glucose (BG) control with insulin in preventing hyperglycemia
during and after coronary artery bypass grafting (CABG) surgery in nondiabetic patients.
Methods: In a randomized clinical trial, 120 nondiabetic patients who underwent elective CABG surgery
were enrolled for study of whether the control of hyperglycemia was a need in such a surgery in
a teaching heart hospital. The patients were randomly divided into study (n ¼ 60) and control (n ¼ 60)
groups. In the study group, insulin was infused to maintain BG level between 110 mg/dL and 126 mg/dL
(a modified insulin therapy protocol, and in the control group, the patients were excepted). Insulin
therapy was limited to intraoperative period. BG levels during surgery and up to 48 hours after surgery
and early postoperative complications were compared between the study and control groups.
Results: One hundred seventeen patients completed the study (59 patients in study group and 58 in
control group). Peak intraoperative BG level in the study group was 126.4 17.9 mg/dL and in the control
group was 137.3 17.6 mg/dL (p ¼ 0.024). The frequencies of severe hyperglycemia (BG 180 mg/dL)
were 6 of 59 (10.1%) in the study group and 19 of 58 (32.7%) in the control group during operation
(p ¼ 0.002). Peak postoperative BG level in the study group was 194.8 41.2 mg/dL and was
199.8 43.2 mg/dL in the control group (p ¼ 0.571). There was no hypoglycemic event in either group.
The frequencies of early postoperative complications were 10 of 59 (16.9%) in the study group and 19 of
58 (32.7%) in the control group (p ¼ 0.047).
Conclusions: Hyperglycemia (BG 126 mg/dL) is common in nondiabetic patients undergoing CABG
surgery. A modified insulin therapy to maintain BG level between 110 mg/dL and 126 mg/dL may be
acceptable for avoiding hypoglycemia and keeping intraoperative BG levels in acceptable range in
nondiabetics. |
| نام فایل |
تاریخ درج فایل |
اندازه فایل |
دانلود |
| Do nondiabetic patients undergoing coronary artery bypass grafting surgery.pdf | 1398/12/21 | 298043 | دانلود |